Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer ; volume:7 ; number:1 ; day:19 ; month:9 ; year:2017 ; pages:1-9 ; date:12.2017
EJNMMI Research ; 7, Heft 1 (19.9.2017), 1-9, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Lake, Spencer T.
- Contributor
-
Greene, Kirsten L.
Westphalen, Antonio C.
Behr, Spencer C.
Zagoria, Ronald
Small, Eric J.
Carroll, Peter R.
Hope, Thomas A.
SpringerLink (Online service)
- DOI
-
10.1186/s13550-017-0327-7
- URN
-
urn:nbn:de:1111-2017111814959
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lake, Spencer T.
- Greene, Kirsten L.
- Westphalen, Antonio C.
- Behr, Spencer C.
- Zagoria, Ronald
- Small, Eric J.
- Carroll, Peter R.
- Hope, Thomas A.
- SpringerLink (Online service)
Other Objects (12)
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
MRI-based attenuation correction for whole body PET-MRI
Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
PET/MRI : methodology and clinical applications
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
MRI-based attenuation correction for whole body PET-MRI
Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
PET/MRI : methodology and clinical applications
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
MRI-based attenuation correction for whole body PET-MRI
Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions